OptimizeRx Corporation

(NASDAQ:OPRX)

Latest On OptimizeRx Corporation (OPRX):

Date/Time Type Description Signal Details
2023-05-11 09:05 ESTNewsOptimizeRx Corporation (OPRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:14 ESTNewsOptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64MN/A
2023-05-10 05:58 ESTNewsOptimizeRx Q1 2023 Earnings PreviewN/A
2023-04-04 01:29 ESTNewsOptimizeRx Has A Good Growth Path AheadN/A
2023-03-14 08:26 ESTNewsOptimizeRx launches $15M stock buyback planN/A
2023-03-09 20:46 ESTNewsOptimizeRx bags contract with Hub services company for better patient accessN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensusN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19%N/A
2023-03-09 05:10 ESTNewsOptimizeRx Corporation (OPRX) Q4 2022 Earnings Call TranscriptN/A
2022-11-09 10:21 ESTNewsOptimizeRx Corporation (OPRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 17:11 ESTNewsOptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08MN/A
2022-11-07 23:01 ESTNewsOptimizeRx Q3 2022 Earnings PreviewN/A
2022-10-25 15:02 ESTNewsOptimizeRx: A Digital Health Marketing Firm That Has Fallen On Hard TimesN/A
2022-10-12 08:35 ESTNewsOptimizeRx: A Top Candidate For My Speculative 'Bio Boom' PortfolioN/A
2022-08-10 21:45 ESTNewsOptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woesN/A
2022-08-10 04:11 ESTNewsOptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensusN/A
2022-08-10 04:11 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:21 ESTNewsOptimizeRx Q2 2022 Earnings PreviewN/A
2022-07-26 19:41 ESTNewsOptimizeRx extends reach with Cooler Screens PartnershipN/A
2022-06-27 13:25 ESTNewsOptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In ProfitabilityN/A
2022-06-26 19:34 ESTNewsOptimizeRx (OPRX) Investor Presentation - SlideshowN/A
2022-05-17 14:46 ESTNewsOptimizeRx authorizes $20M share repurchase programN/A
2022-05-05 07:30 ESTNewsOptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18MN/A
2022-05-05 07:29 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 18:55 ESTNewsOptimizeRx Q1 2022 Earnings PreviewN/A
2022-03-16 08:15 ESTNewsOptimizeRx to acquire specialty drug prescription platform EvincemedN/A
2022-02-25 12:37 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 17:00 ESTNewsOptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5MN/A
2022-02-24 00:04 ESTNewsOptimizeRx Q4 2022 Earnings PreviewN/A
2022-02-16 04:57 ESTNewsOptimizeRx announces preliminary Q4 resultsN/A
2021-11-10 13:38 ESTNewsOptimizeRx EPS misses by $0.04, beats on revenueN/A
2021-11-10 13:38 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:32 ESTNewsOptimizeRx Q3 2021 Earnings PreviewN/A
2021-09-30 20:19 ESTNewsOptimizeRx names Edward Stelmakh as CFO and COON/A
2021-09-29 20:59 ESTNewsOptimizeRx jumps 11% on addition to SmallCap 600 indexN/A
2021-08-05 10:49 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:39 ESTNewsOptimizeRx inks collaboration agreement to drive new patient affordability initiativeN/A
2021-04-20 09:36 ESTNewsOptimizeRx Stock Is Just Getting StartedN/A
2021-03-17 05:40 ESTNewsOptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenueN/A
2021-03-02 12:13 ESTAnalyst RatingThe Analyst Target Price has increased from $65.33 to $75.33.Buy
2021-02-26 12:08 ESTAnalyst RatingThe Analyst Target Price has increased from $61.33 to $65.33.Buy
2021-02-26 04:22 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.07 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.78 is estimated for the 2022 year.Buy
2021-02-25 07:12 ESTNewsOptimizeRx EPS beats by $0.01, beats on revenueN/A
2021-02-25 07:10 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 16:32 ESTNewsOptimizeRx announces proposed public offeringN/A
2021-02-10 16:31 ESTNewsOptimizeRx priced its stock offeringN/A
2021-01-26 12:20 ESTAnalyst RatingThe Analyst Target Price has increased from $53.33 to $61.33.Buy
2021-01-25 20:45 ESTNewsOptimizeRx trades high on positive Q4 guidanceN/A

About OptimizeRx Corporation (OPRX):

OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

OPRX Quotes by TradingView

See Advanced Chart

General

  • Name OptimizeRx Corporation
  • Symbol OPRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryHealth Information Services
  • Full Time Employees 71
  • Last Split Factor1:3
  • Last Split Date2018-05-14
  • Fiscal Year EndDecember
  • IPO Date1996-10-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Technology
  • Gic SubIndustryHealth Care Technology
  • Web URLhttp://www.optimizerx.com
View More

Valuation

  • Forward PE 96.15
  • Price/Sales (Trailing 12 Mt.) 15.5
  • Price/Book (Most Recent Quarter) 15.23
  • Enterprise Value Revenue 17.34
  • Enterprise Value EBITDA 467.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.44
  • Next Year EPS Estimate $0.81
  • Next Quarter EPS Estimate $0.03
  • Profit Margin -5%
  • Operating Margin -3%
  • Return on Assets -1%
  • Return on Equity -5%
  • Revenue 43.31 million
  • Earnings Per Share $0.04
  • Revenue Per Share $2.92
  • Gross Profit 24.11 million
  • Quarterly Earnings Growth 122.6%
View More

Highlights

  • Market Capitalization 839.66 million
  • EBITDA 646895
  • PE Ratio -8.5
  • PEG Ratio 1.93
  • Analyst Target Price $75.33
  • Book Value Per Share $3.28
View More

Share Statistics

  • Shares Outstanding 16.81 million
  • Shares Float 14.36 million
  • % Held by Insiders 1791%
  • % Held by Institutions 65.76%
  • Shares Short 871014
  • Shares Short Prior Month 930303
  • Short Ratio 2.63
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.66
  • 52 Week High $63.98
  • 52 Week Low $6.51
  • 50 Day Moving Average 51.77
  • 200 Day Moving Average 32.49
View More

Dividends

  • Dividend Date 2018-05-14
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

OptimizeRx Corporation (OPRX) Dividend Calendar:

OPRX's last dividend payment was made to shareholders on May 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

OptimizeRx Corporation (OPRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.16$0.163.23%
2020-09-302020-11-09$N/A$0.06$0.0455.75%
2020-06-302020-08-05$N/A$0.02-$0.03166.67%
2020-03-312020-05-04$N/A-$0.06-$0.03-100%
2019-12-312020-02-27$7.38 million-$0.03$0.01-700%
2019-09-302019-11-05$5 million-$0.05$0.08-164.52%
2019-06-302019-08-07$7.01 million$0.09$0.0816.13%
2019-03-312019-05-08$5.21 million$0.06$0.02166.67%
2018-12-312019-02-26$6.58 million$0.06$0.07-18.14%
2018-09-302018-11-05$5.42 million$0.07$0.0623%
2018-06-302018-08-07$5.1 million$0.07$0.03166.8%
2018-03-312018-05-02$4.11 million$0.03-$0.03205%
2017-12-312018-02-27$4.01 million$0.02-$0.03157%
2017-09-302017-11-02$3.1 million-$0.04-$0.03-43%
2017-06-302017-08-01$2.87 million-$0.03
2017-03-312017-05-03$2.15 million-$0.09
2016-12-312017-03-08$2.29 million-$0.04
2016-09-302016-11-07$1.79 million-$0.02
2016-06-302016-08-08$1.91 million-$0.03-$0.030%
2016-03-312016-05-09$1.76 million-$0.01-$0.0366.67%
2015-12-312016-03-15$2.02 million-$0.01
2015-09-302015-11-12$2.01 million$0.01
2015-06-302015-08-11$1.71 million-$0.01
2015-03-312015-05-14$1.49 million-$0.01
2014-12-312015-03-31$1.97 million$0.00$0.01-100%
2014-09-302014-11-13$1.82 million-$0.02
2014-06-302014-08-14$1.43 million-$0.01$0.03-122.67%
2014-03-312014-05-28$1.29 million-$0.12
2013-12-312013-12-31$1.53 million-$0.01
2013-09-302013-09-30$1.37 million$0.00
2013-06-302013-06-30$1.1 million$0.03
2013-03-312013-03-31$669000-$0.02
2012-12-312012-12-31$0.07
2012-09-302012-09-30-$0.02
2012-06-302012-06-30-$0.02
2012-03-312012-03-31-$0.06
2011-12-312011-12-31-$0.11
2011-09-302011-09-30$191593-$0.21
2011-06-302011-06-30$200174-$0.09
2011-03-312011-03-31-$0.05
2010-12-312010-12-31-$0.08
2010-09-302010-09-30-$0.11
2010-06-302010-06-30-$0.20
2010-03-312010-03-31-$0.06
2009-12-312009-12-31-$0.54
2009-09-302009-09-30-$0.12
2009-06-302009-06-30-$0.08
2009-03-312009-03-31-$0.33
2008-12-312008-12-31-$0.84
2008-09-302008-09-30-$0.04
2008-06-302008-06-30-$0.14
2008-03-312008-03-31-$158.21

OptimizeRx Corporation (OPRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

OptimizeRx Corporation (OPRX) Chart:

OptimizeRx Corporation (OPRX) News:

Below you will find a list of latest news for OptimizeRx Corporation (OPRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

OptimizeRx Corporation (OPRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-202.56.5CALL0 3425.2TRUE00
2026-03-2052.7CALL0 11220.8TRUE00
2026-03-207.50.82CALL298 55132TRUE-0.23-0.22
2026-03-20100.31CALL7 250162.94FALSE0.310
2026-03-2012.50.09CALL1 1464164.26FALSE0.090
2026-03-20150.05CALL3 450183.99FALSE0.050
2026-03-2017.50.1CALL0 47413.17FALSE00
2026-03-20200.07CALL0 89240.82FALSE00
2026-03-2022.50.38CALL0 10476.54FALSE00
2026-03-20252.18CALL0 2501.67FALSE00
2026-03-20300.75CALL0 3543.49FALSE00
2026-03-20350.02CALL0 16577.4FALSE00
2026-03-202.50PUT0 0742.2FALSE00
2026-03-2050.12PUT7 1170.29FALSE0.120
2026-03-207.50.76PUT133 181128.75FALSE0.760
2026-03-20100.78PUT0 11123.8TRUE00
2026-03-2012.54.19PUT0 4120TRUE00
2026-03-20157.16PUT0 130TRUE00
2026-03-2017.510.15PUT0 20TRUE00
2026-03-20200PUT0 00TRUE00
2026-03-2022.50PUT0 00TRUE00
2026-03-20258.9PUT0 00TRUE00
2026-03-20300PUT0 0352.64TRUE00
2026-03-20350PUT0 0382.85TRUE00
2026-04-172.50CALL0 0248.66TRUE00
2026-04-1752.2CALL1000 404179.12TRUE2.20
2026-04-177.51.05CALL23 099.66TRUE1.050
2026-04-17100.44CALL2 357110.9FALSE0.440
2026-04-1712.50CALL0 0187.33FALSE00
2026-04-17150CALL0 0218.85FALSE00
2026-04-1717.50CALL0 0243.58FALSE00
2026-04-172.50PUT0 0439.32FALSE00
2026-04-1750.34PUT0 1209.88FALSE00
2026-04-177.51PUT0 3105.64FALSE00
2026-04-17100PUT0 075.86TRUE00
2026-04-1712.50PUT0 088.41TRUE00
2026-04-17150PUT0 00TRUE00
2026-04-1717.50PUT0 00TRUE00
2026-06-182.50CALL0 0181.32TRUE00
2026-06-1858.6CALL0 4122.67TRUE00
2026-06-187.51.8CALL0 9120.55TRUE00
2026-06-18102.2CALL0 2126.01FALSE00
2026-06-1812.51CALL0 35132.61FALSE00
2026-06-18150.65CALL0 9142.95FALSE00
2026-06-1817.51.4CALL0 16155.26FALSE00
2026-06-18200.2CALL0 71168.27FALSE00
2026-06-1822.50.58CALL0 3179.28FALSE00
2026-06-18253.3CALL0 5188.81FALSE00
2026-06-18300CALL0 0204.65FALSE00
2026-06-18350CALL0 0340.09FALSE00
2026-06-182.50PUT0 0282.42FALSE00
2026-06-1850PUT0 0230.75FALSE00
2026-06-187.51.8PUT0 397.82FALSE00
2026-06-18102.94PUT0 31114.68TRUE00
2026-06-1812.53.3PUT0 286.49TRUE00
2026-06-18150PUT0 00TRUE00
2026-06-1817.50PUT0 00TRUE00
2026-06-18200PUT0 00TRUE00
2026-06-1822.50PUT0 00TRUE00
2026-06-18257.7PUT0 10TRUE00
2026-06-18300PUT0 00TRUE00
2026-06-18350PUT0 0154.19TRUE00
2026-09-182.50CALL0 0138.11TRUE00
2026-09-1857.2CALL0 1121.27TRUE00
2026-09-187.55.93CALL0 1131.57TRUE00
2026-09-18101.25CALL0 6114.91FALSE00
2026-09-1812.50.89CALL0 387.49FALSE00
2026-09-18150.6CALL0 31287.31FALSE00
2026-09-1817.51.4CALL0 20112.7FALSE00
2026-09-18201CALL0 5122.23FALSE00
2026-09-1822.50CALL0 0130.29FALSE00
2026-09-18250CALL0 0137.26FALSE00
2026-09-182.50PUT0 0207.53FALSE00
2026-09-1850.7PUT100 096.42FALSE0.70
2026-09-187.51.28PUT0 136109.27FALSE00
2026-09-18102.9PUT0 286.02TRUE00
2026-09-1812.50PUT0 084.01TRUE00
2026-09-18150PUT0 074.02TRUE00
2026-09-1817.50PUT0 080.75TRUE00
2026-09-18200PUT0 00TRUE00
2026-09-1822.50PUT0 00TRUE00
2026-09-18250PUT0 00TRUE00

Latest OPRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$25.31
Jun 13, 2022 7:59 PM EST85$25.28
Jun 13, 2022 7:59 PM EST30$25.32
Jun 13, 2022 7:59 PM EST23$25.32
Jun 13, 2022 8:45 PM EST2$25.99

OptimizeRx Corporation (OPRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-02-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1448431/000103347520000005/0001033475-20-000005-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020004998/0001213900-20-004998-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005137/0001213900-20-005137-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005258/0001213900-20-005258-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005596/0001213900-20-005596-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005688/0001213900-20-005688-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005874/0001213900-20-005874-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005969/0001213900-20-005969-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006161/0001213900-20-006161-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006356/0001213900-20-006356-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006358/0001213900-20-006358-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006360/0001213900-20-006360-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006361/0001213900-20-006361-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006460/0001213900-20-006460-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1448431/000121390020006534/0001213900-20-006534-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006751/0001213900-20-006751-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020007331/0001213900-20-007331-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/0001213900-20-007491-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008456/0001213900-20-008456-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008624/0001213900-20-008624-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008867/0001213900-20-008867-index.htm
2020-04-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008955/0001213900-20-008955-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009315/0001213900-20-009315-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009488/0001213900-20-009488-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009800/0001213900-20-009800-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020010957/0001213900-20-010957-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011117/0001213900-20-011117-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020011158/0001213900-20-011158-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011286/0001213900-20-011286-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011394/0001213900-20-011394-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012040/0001213900-20-012040-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012894/0001213900-20-012894-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020013773/0001213900-20-013773-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014568/0001213900-20-014568-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015991/0001213900-20-015991-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016166/0001213900-20-016166-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016870/0001213900-20-016870-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017235/0001213900-20-017235-index.htm
2020-07-10144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017236/0001213900-20-017236-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018238/0001213900-20-018238-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018352/0001213900-20-018352-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018775/0001213900-20-018775-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020020375/0001213900-20-020375-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020566/0001213900-20-020566-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020802/0001213900-20-020802-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021320/0001213900-20-021320-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023057/0001213900-20-023057-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023388/0001213900-20-023388-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025765/0001213900-20-025765-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020026656/0001213900-20-026656-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020027474/0001213900-20-027474-index.htm
2020-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020029583/0001213900-20-029583-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031051/0001213900-20-031051-index.htm
2020-10-16144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031790/0001213900-20-031790-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020033259/0001213900-20-033259-index.htm

OptimizeRx Corporation (OPRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OptimizeRx Corporation (OPRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1791%
Institutional Ownership: 6576%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-06DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0017.01170,100.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-13DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0018.00180,000.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-14DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07GREGORY D WASSONDirectorBuy15,000.0017.49262,350.0015,000.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-03-04WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy30,000.003.2196,300.00163,267.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-30Patrick D SpanglerDirectorBuy2,784.0017,467.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-06-30Patrick D SpanglerDirectorBuy1,937.0019,404.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-06-24WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy45,261.003.21145,287.81208,528.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-30WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy21,187.00229,719.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-03-30Ellen O'Connor VosDirectorBuy2,784.0027,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-30James Paul LangDirectorBuy2,784.0027,792.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-31Ellen O'Connor VosDirectorBuy1,000.008.758,750.0028,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-06-30James Paul LangDirectorBuy1,937.0029,729.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-06-30Ellen O'Connor VosDirectorBuy1,937.0029,959.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-03-30GUS D HALASDirectorBuy2,784.0059,960.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-06-30GUS D HALASDirectorBuy1,937.0061,897.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0020.00200,000.0080,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-07-16DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell6,667.0015.00100,005.0082,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-06-03DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy17,421.003.1554,876.1589,338.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-07-17DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy8,000.002.4619,680.0090,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.0090,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm